SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (445)2/12/1999 4:06:00 PM
From: Biomaven  Read Replies (1) | Respond to of 1494
 
John,

I believe the memantine trials (neuropathy and AIDS dementia) are required by their agreement with Merz. I guess the Xerecept trial could be suspended if they are desperate (although this is the one they just got a grant for).

My instinct is that they will get some sort of funding and be able to continue - there's enough potential value here to warrant funding.

Peter